|
|
||||||||
B Activation1




*
Facultad de Ciencias Médicas, Instituto de Immunología, Rosario, Argentina;
Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Biología Molecular y Celular de Rosario Consejo Nacional de Invetigaciones Cientìficas y Técnicas de Argentina, Rosario, Argentina; and
Institut National de la Santé et de la Recherche Médicale Unite 365, Institut Curie, Section de Recherche, Paris, France
In murine macrophages, inducible NO synthase II (NOSII) gene
expression is promoted at a transcriptional level by LPS and/or IFN-
with benznidazole (BZL), a trypanocidal drug, acting to down-regulate
NOSII gene induction and hence inhibiting NO production. By performing
transient transfection experiments, we now report that BZL also
inhibited the expression of NOSII gene promoter or multimerized NF-
B
binding site controlled reporter genes. By contrast, no effect was
observed on the expression of a reporter gene under the control of the
NOSII promoter-derived IFN regulatory factor element. EMSAs
demonstrated that BZL inhibited the nuclear availability of NF-
B in
stimulated macrophages. NF-
B is activated in macrophages by
phosphorylation, ubiquitination, and subsequent proteolysis of I
B.
Within this setting, Western blot was also performed to show that BZL
blocked I
B
degradation. Collectively, these results demonstrate
that BZL is able to specifically inhibit macrophage NF-
B activation
after LPS plus IFN-
stimulation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |